Related Experiment Video
Updated: Jun 13, 2026
10:08
Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
Voltage-gated K+ channel modulators as neuroprotective agents.
1Graduate Institute of Neural and Cognitive Sciences, China Medical University, Taichung, Taiwan, ROC. ymleung@mail.cmu.edu.tw
Life Sciences
|April 14, 2010
Summary
Voltage-gated potassium (Kv) channels regulate neuronal apoptosis. Modulating Kv channels may prevent neuron loss in neurodegenerative diseases and epilepsy by controlling potassium efflux.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Neuronal apoptosis, a hallmark of neurodegeneration, involves cytosolic K+ efflux through voltage-gated K+ (Kv) channels.
- This K+ loss activates pro-apoptotic enzymes, leading to programmed cell death.
- Kv channel dysfunction contributes to neuronal hyperexcitability in diseases like epilepsy, potentially causing apoptosis.
Purpose of the Study:
- To review the role of Kv channels in neuronal apoptosis.
- To explore the therapeutic potential of Kv channel modulators for neuroprotection.
- To discuss Kv channel modulators as a treatment strategy for neurological disorders.
Main Methods:
- Literature review of Kv channel function in neuronal apoptosis.
- Analysis of Kv channel subtypes (A-type, Kv7) in neurodegeneration and epilepsy.
- Examination of Kv channel modulators as neuroprotective agents.
Main Results:
- Kv channel blockers prevent K+ efflux and subsequent neuronal apoptosis.
- Reduced activity of A-type Kv and Kv7 channels is linked to neuronal hyperexcitation and apoptosis.
- Targeting Kv channels offers a promising neuroprotective strategy.
Conclusions:
- Kv channel modulation represents a viable therapeutic approach for neurodegenerative conditions.
- Enhancing Kv channel activity may counteract neuronal hyperexcitability and prevent apoptosis.
- Kv channel modulators hold potential as neuroprotective drugs for various neurological diseases.
Related Concept Videos
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:26Voltage-gated Ion Channels
Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:19Ligand-gated Ion Channels
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that include the...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...